Literature DB >> 11089639

A model for the complex between the hypoxia-inducible factor-1 (HIF-1) and its consensus DNA sequence.

G Michel1, E Minet, I Ernest, I Roland, F Durant, J Remacle, C Michiels.   

Abstract

Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor activated by hypoxia. When activated, HIF-1 mediates the differential expression of genes such as erythropoietin and Vascular Endothelial Growth Factor (VEGF) during hypoxia. It is composed of two different subunits, HIF-1alpha and ARNT (Aryl Receptor Nuclear Translocator). These two subunits belong to the bHLH (basic Helix-Loop-Helix) PAS (Per, Ahr/ARNT, Sim) family. The bHLH domain of these factors is responsible for dimerization through the two helices and for DNA binding through their basic domain. In this work, we used various methods of molecular modeling in order to develop a 3D structure for the HIF-1 bHLH domain bound to its DNA consensus sequence. Firstly, the 3D structure of the bHLH domain of both subunits based on their amino acid sequence was defined. Secondly, we compared this model with data from known crystal structures of basic leucine zipper-DNA and bHLH-DNA complexes in order to determine a potential canvas for HIF-1. Thirdly, we performed a manual approach of the HIF-1 bHLH domain onto the DNA recognition site using this canvas. Finally, the protein-DNA complex 3D structure was optimized using a Monte Carlo program called MONTY. The model predicted a pattern of interactions between amino acids and DNA bases which reflect for ARNT what is experimentally observed among different X-ray structures of other bHLH transcription factors possessing the H (His), E (Glu), R (Arg) triad, as ARNT does. On the other hand, only the Arg residue is conserved in HIF- 1alpha. We propose from this model that a serine replaces the histidine while an alanine and a lysine also make contacts with DNA. From these results, we postulate that the specificity of HIF-1 toward its DNA sequence could be driven by the HIF-1alpha subunit. The predicted model will be verified by X-Ray currently ongoing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089639     DOI: 10.1080/07391102.2000.10506656

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  6 in total

1.  Altered DNA binding specificity of Arnt by selection of partner bHLH-PAS proteins.

Authors:  Koshi Kinoshita; Yasuo Kikuchi; Yukie Sasakura; Masashi Suzuki; Yoshiaki Fujii-Kuriyama; Kazuhiro Sogawa
Journal:  Nucleic Acids Res       Date:  2004-06-09       Impact factor: 16.971

2.  Regulation of the Drosophila hypoxia-inducible factor alpha Sima by CRM1-dependent nuclear export.

Authors:  Nuria M Romero; Maximiliano Irisarri; Peggy Roth; Ana Cauerhff; Christos Samakovlis; Pablo Wappner
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

Review 3.  Hypoxia-inducible factor-1 in tumour angiogenesis.

Authors:  Yong-Hong Shi; Wei-Gang Fang
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

4.  Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803.

Authors:  Luke A McNeill; Kirsty S Hewitson; Timothy D Claridge; Jürgen F Seibel; Louise E Horsfall; Christopher J Schofield
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

5.  A flexible integrative approach based on random forest improves prediction of transcription factor binding sites.

Authors:  Bart Hooghe; Stefan Broos; Frans van Roy; Pieter De Bleser
Journal:  Nucleic Acids Res       Date:  2012-04-05       Impact factor: 16.971

6.  Hypoxia increases chemoresistance in human medulloblastoma DAOY cells via hypoxia‑inducible factor 1α‑mediated downregulation of the CYP2B6, CYP3A4 and CYP3A5 enzymes and inhibition of cell proliferation.

Authors:  Jesús Valencia-Cervantes; Sara Huerta-Yepez; Guillermo Aquino-Jarquín; Sara Rodríguez-Enríquez; Daniel Martínez-Fong; José-Antonio Arias-Montaño; Víctor Manuel Dávila-Borja
Journal:  Oncol Rep       Date:  2018-10-12       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.